Akari Therapeutics Plc Stock Price History

AKTX Stock  USD 1.21  0.09  8.04%   
Below is the normalized historical share price chart for Akari Therapeutics PLC extending back to May 07, 2013. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Akari Therapeutics stands at 1.21, as last reported on the 30th of November, with the highest price reaching 1.28 and the lowest price hitting 1.15 during the day.
IPO Date
21st of September 2015
200 Day MA
2.5482
50 Day MA
2.6737
Beta
0.951
 
Yuan Drop
 
Covid
If you're considering investing in Akari Stock, it is important to understand the factors that can impact its price. Akari Therapeutics PLC secures Sharpe Ratio (or Efficiency) of -0.21, which signifies that the company had a -0.21% return per unit of standard deviation over the last 3 months. Akari Therapeutics PLC exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Akari Therapeutics' risk adjusted performance of (0.15), and Mean Deviation of 4.64 to double-check the risk estimate we provide.
  
At this time, Akari Therapeutics' Stock Based Compensation is fairly stable compared to the past year. Sale Purchase Of Stock is likely to rise to about 16.9 M in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 4.7 M in 2024. . Price Earnings Ratio is likely to drop to -1.6 in 2024. Price Book Value Ratio is likely to rise to -63.35 in 2024. Akari Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.2072

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsAKTX

Estimated Market Risk

 7.12
  actual daily
63
63% of assets are less volatile

Expected Return

 -1.47
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.21
  actual daily
0
Most of other assets perform better
Based on monthly moving average Akari Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Akari Therapeutics by adding Akari Therapeutics to a well-diversified portfolio.
Price Book
3.0692
Book Value
(0.04)
Enterprise Value
26.5 M
Enterprise Value Ebitda
(0.06)
Shares Float
10.5 B

Akari Therapeutics Stock Price History Chart

There are several ways to analyze Akari Stock price data. The simplest method is using a basic Akari candlestick price chart, which shows Akari Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceSeptember 11, 20243.5
Lowest PriceNovember 25, 20241.03

Akari Therapeutics November 30, 2024 Stock Price Synopsis

Various analyses of Akari Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Akari Stock. It can be used to describe the percentage change in the price of Akari Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Akari Stock.
Akari Therapeutics Price Action Indicator 0.04 
Akari Therapeutics Price Rate Of Daily Change 1.08 
Akari Therapeutics Accumulation Distribution 5,950 
Akari Therapeutics Price Daily Balance Of Power 0.69 

Akari Therapeutics November 30, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Akari Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Akari Therapeutics intraday prices and daily technical indicators to check the level of noise trading in Akari Stock and then apply it to test your longer-term investment strategies against Akari.

Akari Stock Price History Data

The price series of Akari Therapeutics for the period between Sun, Sep 1, 2024 and Sat, Nov 30, 2024 has a statistical range of 2.8 with a coefficient of variation of 26.41. The prices are distributed with arithmetic mean of 2.64. The median price for the last 90 days is 2.66. The company had 1:20 stock split on 17th of August 2023.
OpenHighLowCloseVolume
11/29/2024 1.20  1.28  1.15  1.21  58,586 
11/27/2024 1.12  1.15  1.06  1.12  42,298 
11/26/2024 1.10  1.19  0.90  1.14  157,623 
11/25/2024 1.30  1.31  1.03  1.03  193,505 
11/22/2024 1.23  1.33  1.10  1.30  142,223 
11/21/2024 1.45  1.45  1.10  1.24  178,031 
11/20/2024 1.68  1.68  1.46  1.47  97,567 
11/19/2024 2.45  2.45  1.49  1.57  312,816 
11/18/2024 2.20  2.33  2.20  2.29  19,920 
11/15/2024 2.17  2.17  1.77  2.08  19,448 
11/14/2024 2.40  2.40  2.23  2.23  5,644 
11/13/2024 2.23  2.39  2.23  2.24  5,517 
11/12/2024 2.28  2.30  2.25  2.30  1,958 
11/11/2024 2.32  2.38  2.21  2.30  12,504 
11/08/2024 2.52  2.56  2.28  2.45  20,580 
11/07/2024 2.28  2.43  2.28  2.43  2,076 
11/06/2024 2.43  2.43  2.21  2.32  9,697 
11/05/2024 2.39  2.50  2.22  2.43  39,553 
11/04/2024 2.91  2.91  2.20  2.43  50,984 
11/01/2024 2.54  3.15  2.43  2.78  47,292 
10/31/2024 2.44  2.57  2.40  2.40  4,439 
10/30/2024 2.58  2.58  2.32  2.41  12,123 
10/29/2024 2.47  2.50  2.36  2.50  25,731 
10/28/2024 2.30  2.49  2.30  2.40  2,296 
10/25/2024 2.26  2.50  2.25  2.36  12,499 
10/24/2024 2.25  2.44  2.21  2.27  17,468 
10/23/2024 2.13  2.21  2.13  2.21  1,940 
10/22/2024 2.23  2.25  2.10  2.13  11,160 
10/21/2024 2.23  2.33  2.14  2.16  8,912 
10/18/2024 2.26  2.49  2.22  2.24  8,488 
10/17/2024 2.44  2.49  2.20  2.21  9,335 
10/16/2024 2.72  2.73  2.40  2.52  2,491 
10/15/2024 2.83  2.88  2.37  2.55  14,620 
10/14/2024 2.65  2.87  2.51  2.66  24,130 
10/11/2024 2.52  2.99  2.52  2.70  9,862 
10/10/2024 2.97  2.97  2.64  2.64  22,838 
10/09/2024 3.13  3.13  2.80  2.95  36,970 
10/08/2024 3.01  3.19  3.00  3.06  3,436 
10/07/2024 2.97  3.70  2.56  3.04  14,065 
10/04/2024 2.99  3.01  2.76  3.01  3,431 
10/03/2024 2.96  3.10  2.94  3.00  2,190 
10/02/2024 3.15  3.24  2.88  2.98  5,059 
10/01/2024 2.78  3.00  2.78  3.00  10,689 
09/30/2024 3.00  3.00  2.91  2.95  1,720 
09/27/2024 3.05  3.26  2.90  2.94  11,654 
09/26/2024 3.16  3.85  2.67  3.05  228,222 
09/25/2024 2.96  3.21  2.96  3.16  3,342 
09/24/2024 3.06  3.25  2.57  2.98  15,179 
09/23/2024 3.20  3.20  3.20  3.20  335.00 
09/20/2024 3.15  3.22  3.15  3.22  617.00 
09/19/2024 3.23  3.25  3.08  3.16  3,245 
09/18/2024 3.40  3.40  3.14  3.14  3,293 
09/17/2024 3.41  3.49  3.20  3.32  7,057 
09/16/2024 3.45  3.45  3.15  3.27  11,863 
09/13/2024 3.50  3.58  3.18  3.26  5,726 
09/12/2024 3.41  3.41  3.24  3.30  12,618 
09/11/2024 3.58  3.59  3.20  3.50  9,687 
09/10/2024 3.38  3.64  3.38  3.42  1,727 
09/09/2024 3.25  3.39  3.15  3.30  8,292 
09/06/2024 3.45  3.79  3.32  3.32  6,461 
09/05/2024 3.82  3.82  3.25  3.25  10,043 

About Akari Therapeutics Stock history

Akari Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Akari is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Akari Therapeutics PLC will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Akari Therapeutics stock prices may prove useful in developing a viable investing in Akari Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding4.9 M4.7 M
Net Loss-20 M-21 M

Akari Therapeutics Stock Technical Analysis

Akari Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Akari Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Akari Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run USA ETFs Now

   

USA ETFs

Find actively traded Exchange Traded Funds (ETF) in USA
All  Next Launch Module

Akari Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Akari Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Akari Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Akari to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Akari Stock Analysis

When running Akari Therapeutics' price analysis, check to measure Akari Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Akari Therapeutics is operating at the current time. Most of Akari Therapeutics' value examination focuses on studying past and present price action to predict the probability of Akari Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Akari Therapeutics' price. Additionally, you may evaluate how the addition of Akari Therapeutics to your portfolios can decrease your overall portfolio volatility.